2006
DOI: 10.1007/s11064-006-9085-z
|View full text |Cite
|
Sign up to set email alerts
|

High Glutamate Decreases S100B Secretion by a Mechanism Dependent on the Glutamate Transporter

Abstract: Several molecules have been shown to be involved in glial-neuronal communication, including S100B, an astrocyte-derived neurotrophic cytokine. Extracellular S100B protects hippocampal neurons from excitotoxic damage, whilst toxic levels of glutamate to neurons have been shown to reduce S100B secretion in astrocytes and brain slices, by an unknown mechanism. Here, we investigate which mechanisms are possibly involved in this effect in primary cultures of hippocampal astrocytes using glutamate agonists and gluta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
25
0
4

Year Published

2006
2006
2015
2015

Publication Types

Select...
9
1

Relationship

4
6

Authors

Journals

citations
Cited by 44 publications
(32 citation statements)
references
References 29 publications
3
25
0
4
Order By: Relevance
“…19 The release of S100B is inversely proportional to the Abbreviations: C, control; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; MDD, major depressive disorder; PMI, post-mortem interval; S, suicide; SMD, suicide with major depression. uptake of glutamate, 20 suggesting that the altered expression of glutamate receptor subunits, transporters and GLUL witnessed here may be part of a larger glial deficit precipitated through multiple mechanisms. The g-1 and g-2 GABA-A receptor subunits (GABRG1 and GABRG2), GLUL and the GABA transporter (SLC6A1) are part of a larger group of genes controlling GABA synthesis, neurotransmission and turnover, many of which are misexpressed to varying degrees in these cortical areas.…”
Section: Discussionmentioning
confidence: 90%
“…19 The release of S100B is inversely proportional to the Abbreviations: C, control; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; MDD, major depressive disorder; PMI, post-mortem interval; S, suicide; SMD, suicide with major depression. uptake of glutamate, 20 suggesting that the altered expression of glutamate receptor subunits, transporters and GLUL witnessed here may be part of a larger glial deficit precipitated through multiple mechanisms. The g-1 and g-2 GABA-A receptor subunits (GABRG1 and GABRG2), GLUL and the GABA transporter (SLC6A1) are part of a larger group of genes controlling GABA synthesis, neurotransmission and turnover, many of which are misexpressed to varying degrees in these cortical areas.…”
Section: Discussionmentioning
confidence: 90%
“…In vitro, extracellular S100B and S100A4 promote neurite outgrowth and neuronal survival by acting through the receptor for advanced glycation end products and heparan sulfate proteoglycans, respectively, both of which are present at the cell surface (29). Moreover, extracellular S100B has been shown to modulate long term neuronal synaptic plasticity (30), glutamate uptake of hippocampal astrocytes (31), and inflammation (32) (for review see Ref. 33).…”
mentioning
confidence: 99%
“…Therefore, S100B could improve the recycling of glutamate in schizophrenia. Contrarily, another study has demonstrated that glutamate inhibits the release of S100B from astrocytes 34 . In conclusion, an increased S100B release from astrocytes may arise in schizophrenia patients due to reduced availability of glutamate, as a counterregulatory mechanism.…”
Section: Potential Links Between S100b and The Pathogenesis Of Schizomentioning
confidence: 99%